FDA Guidance for Industry: Cannabis and Cannabis-Derived Compounds: Quality Considerations for Clinical Research

Titel:
FDA Guidance for Industry: Cannabis and Cannabis-Derived Compounds: Quality Considerations for Clinical Research
Herkunft/Verlag:

FDA

Inhalt:
This guidance outlines FDA’s current thinking on several topics relevant to clinical research related to the development of drugs containing cannabis or cannabis-derived compounds

Zurück

GMP Seminare nach Thema